Duchenne and Becker Muscular Dystrophy Study in Western China
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study tracks how Duchenne and Becker muscular dystrophy progress in children over time in Western China. By following patients regularly, researchers hope to better understand the disease course and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is male and has a genetic test confirming Duchenne or Becker muscular dystrophy
- Child is between 1 and 18 years old
- Child can attend study visits and complete health assessments
- Parent or legal guardian can provide written permission for the child to participate
- Child does not have other muscle or nerve disorders that would confuse the study results
- Child is not enrolled in another treatment trial that could affect disease progression
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
This study follows boys with Duchenne muscular dystrophy over time to better understand how the condition changes and how standard treatments affect health and function. It does not appear to test a new medicine, but it may help doctors plan better future care and studies.
This study follows people with Duchenne muscular dystrophy (a muscle-weakening condition) to track how the disease progresses over time. By collecting this data, researchers hope to better understand the condition and improve future care.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study collects information from patients with Duchenne or Becker muscular dystrophy to learn more about the conditions and improve care. You will share data through a telemedicine platform, and you need a smartphone or tablet to take part.
This study tracks the natural history of Duchenne Muscular Dystrophy over time. It collects information from patients at four centers to better understand how the disease progresses, which may help improve care in the future.
Hear when a new Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.